{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T06:10:05Z","timestamp":1749190205476,"version":"3.41.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:00:00Z","timestamp":1715040000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biochem Genet"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10528-024-10735-3","type":"journal-article","created":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T10:02:01Z","timestamp":1715076121000},"page":"2211-2224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Application of PLK1 and HOXA13 Gene Expression Levels in Urine in the Diagnosis of Non-muscle Invasive Bladder Cancer"],"prefix":"10.1007","volume":"63","author":[{"given":"Sahar","family":"Valizadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sana","family":"Taghiyar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serajedin","family":"Vahidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omid","family":"Abazari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmood","family":"Akhavan Tafti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javad","family":"Zavar Reza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,5,7]]},"reference":[{"issue":"24","key":"10735_CR1","doi-asserted-by":"publisher","first-page":"1897","DOI":"10.1093\/jnci\/djs444","volume":"104","author":"AF Amaral","year":"2012","unstructured":"Amaral AF, M\u00e9ndez-Pertuz M, Mu\u00f1oz A, Silverman DT, Allory Y, Kogevinas M, Rivas del Fresno M (2012) Plasma 25-hydroxyvitamin D3 and bladder cancer risk according to tumor stage and FGFR3 status: a mechanism-based epidemiological study. J Natl Cancer Inst 104(24):1897\u20131904","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"10735_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0210635","volume":"14","author":"A Apollo","year":"2019","unstructured":"Apollo A, Ortenzi V, Scatena C, Zavaglia K, Aretini P, Lessi F, Viacava P (2019) Molecular characterization of low grade and high grade bladder cancer. PLoS ONE 14(1):e0210635","journal-title":"PLoS ONE"},{"issue":"1","key":"10735_CR3","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/diagnostics10010039","volume":"10","author":"R Batista","year":"2020","unstructured":"Batista R, Vinagre N, Meireles S, Vinagre J, Prazeres H, Le\u00e3o R, Soares P (2020) Biomarkers for bladder cancer diagnosis and surveillance: a comprehensive review. Diagnostics 10(1):39","journal-title":"Diagnostics"},{"issue":"6","key":"10735_CR4","first-page":"1104","volume":"9","author":"A Chakraborty","year":"2019","unstructured":"Chakraborty A, Dasari S, Long W, Mohan C (2019) Urine protein biomarkers for the detection, surveillance, and treatment response prediction of bladder cancer. Am J Cancer Res 9(6):1104","journal-title":"Am J Cancer Res"},{"issue":"16","key":"10735_CR5","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.3390\/diagnostics13162636","volume":"13","author":"F-W Chin","year":"2023","unstructured":"Chin F-W, Hussin H, Chau D-M, Ong T-A, Yunus R, Abdul Razack AH, Veerakumarasivam A (2023) Differential protein expression patterns of HOXA13 and HOXB13 are associated with bladder cancer progression. Diagnostics 13(16):2636","journal-title":"Diagnostics"},{"issue":"6","key":"10735_CR6","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S0959-8049(05)80432-0","volume":"29","author":"G De Vita","year":"1993","unstructured":"De Vita G, Barba P, Odartchenko N, Givel J-C, Freschi G, Bucciarelli G, Cillo C (1993) Expression of homeobox-containing genes in primary and metastatic colorectal cancer. Eur J Cancer 29(6):887\u2013893","journal-title":"Eur J Cancer"},{"key":"10735_CR7","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s00508-016-1108-4","volume":"129","author":"H Hu","year":"2017","unstructured":"Hu H, Chen Y, Cheng S, Li G, Zhang Z (2017) Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer. Wien Klin Wochenschr 129:391\u2013397","journal-title":"Wien Klin Wochenschr"},{"key":"10735_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114747","volume":"193","author":"S Iliaki","year":"2021","unstructured":"Iliaki S, Beyaert R, Afonina IS (2021) Polo-like kinase 1 (PLK1) signaling in cancer and beyond. Biochem Pharmacol 193:114747","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"10735_CR9","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1158\/1535-7163.MCT-16-0361","volume":"16","author":"J Li","year":"2017","unstructured":"Li J, Wang R, Kong Y, Broman MM, Carlock C, Chen L, Liu X (2017) Targeting Plk1 to enhance efficacy of olaparib in castration-resistant prostate cancer. Mol Cancer Ther 16(3):469\u2013479","journal-title":"Mol Cancer Ther"},{"issue":"39","key":"10735_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030723","volume":"101","author":"B Liu","year":"2022","unstructured":"Liu B, Meng L-B, Su J-Z, Fan B, Zhao S-B, Wang H-Y, Ni X-C (2022) Plk1 as one novel target for the poor prognosis of bladder cancer: an observational study. Medicine 101(39):e30723","journal-title":"Medicine"},{"issue":"9","key":"10735_CR11","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.3390\/ijms19092514","volume":"19","author":"I Lodewijk","year":"2018","unstructured":"Lodewijk I, Due\u00f1as M, Rubio C, Munera-Maravilla E, Segovia C, Bernardini A, Su\u00e1rez-Cabrera C (2018) Liquid biopsy biomarkers in bladder cancer: a current need for patient diagnosis and monitoring. Int J Mol Sci 19(9):2514","journal-title":"Int J Mol Sci"},{"issue":"3A","key":"10735_CR12","first-page":"2101","volume":"23","author":"IG Maroulakou","year":"2003","unstructured":"Maroulakou IG, Spyropoulos DD (2003) The study of HOX gene function in hematopoietic, breast and lung carcinogenesis. Anticancer Res 23(3A):2101\u20132110","journal-title":"Anticancer Res"},{"key":"10735_CR13","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00428-014-1596-4","volume":"465","author":"Y Neuzillet","year":"2014","unstructured":"Neuzillet Y, van Rhijn BW, Prigoda NL, Bapat B, Liu L, Bostrom PJ, Jewett MA (2014) FGFR3 mutations, but not FGFR3 expression and FGFR3 copy-number variations, are associated with favourable non-muscle invasive bladder cancer. Virchows Arch 465:207\u2013213","journal-title":"Virchows Arch"},{"issue":"1","key":"10735_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2017.22","volume":"3","author":"O Sanli","year":"2017","unstructured":"Sanli O, Dobruch J, Knowles MA, Burger M, Alemozaffar M, Nielsen ME, Lotan Y (2017) Bladder cancer. Nat Rev Dis Primers 3(1):1\u201319","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10735_CR15","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1093\/jb\/mvi086","volume":"137","author":"V Scott","year":"2005","unstructured":"Scott V, Morgan EA, Stadler HS (2005) Genitourinary functions of Hoxa13 and Hoxd13. J Biochem 137(6):671\u2013676","journal-title":"J Biochem"},{"issue":"9","key":"10735_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.24606","volume":"36","author":"N Setti Boubaker","year":"2022","unstructured":"Setti Boubaker N, Gurtner A, Trabelsi N, Manni I, Blel A, Saadi A, Ksontini M (2022) An insight into the diagnostic and prognostic value of HOX A13\u2019s expression in non-muscle invasive bladder cancer. J Clin Lab Anal 36(9):e24606","journal-title":"J Clin Lab Anal"},{"issue":"8","key":"10735_CR17","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/07357907.2018.1514504","volume":"36","author":"S Seyedabadi","year":"2018","unstructured":"Seyedabadi S, Saidijam M, Najafi R, Mousavi-Bahar SH, Jafari M, MohammadGanji S, Mahdavinezhad A (2018) Assessment of CEP55, PLK1 and FOXM1 expression in patients with bladder cancer in comparison with healthy individuals. Cancer Invest 36(8):407\u2013414","journal-title":"Cancer Invest"},{"issue":"1","key":"10735_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A (2023) Cancer statistics, 2023. CA Cancer J Clin 73(1):17\u201348","journal-title":"CA Cancer J Clin"},{"key":"10735_CR19","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ctrv.2018.05.012","volume":"69","author":"WS Tan","year":"2018","unstructured":"Tan WS, Tan WP, Tan M-Y, Khetrapal P, Dong L, deWinter P, Kelly JD (2018) Novel urinary biomarkers for the detection of bladder cancer: a systematic review. Cancer Treat Rev 69:39\u201352","journal-title":"Cancer Treat Rev"},{"issue":"25","key":"10735_CR20","doi-asserted-by":"publisher","first-page":"38731","DOI":"10.18632\/oncotarget.9587","volume":"7","author":"V Urquidi","year":"2016","unstructured":"Urquidi V, Netherton M, Gomes-Giacoia E, Serie D, Eckel-Passow J, Rosser CJ, Goodison S (2016) Urinary mRNA biomarker panel for the detection of urothelial carcinoma. Oncotarget 7(25):38731","journal-title":"Oncotarget"},{"key":"10735_CR21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.18063\/cp.v3i1.302","volume":"3","author":"H Wei","year":"2021","unstructured":"Wei H, Wan W, Zhan H, Wang J, Chen J (2021) The role of FGFR3 in the diagnosis and treatment of bladder cancer: a review. Cancer Plus 3:28","journal-title":"Cancer Plus"},{"issue":"5","key":"10735_CR22","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1158\/0008-5472.CAN-16-1378","volume":"77","author":"X Yang","year":"2017","unstructured":"Yang X, Chen G, Li W, Peng C, Zhu Y, Yang X, Pei H (2017) Cervical cancer growth is regulated by a c-ABL\u2013PLK1 signaling axis. Cancer Res 77(5):1142\u20131154","journal-title":"Cancer Res"},{"issue":"1","key":"10735_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-017-3884-2","volume":"17","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Zhang G, Gao Z, Li S, Li Z, Bi J, Kong C (2017) Comprehensive analysis of differentially expressed genes associated with PLK1 in bladder cancer. BMC Cancer 17(1):1\u201311","journal-title":"BMC Cancer"}],"container-title":["Biochemical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10735-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10528-024-10735-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10528-024-10735-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T05:52:22Z","timestamp":1749189142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10528-024-10735-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,7]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10735"],"URL":"https:\/\/doi.org\/10.1007\/s10528-024-10735-3","relation":{},"ISSN":["0006-2928","1573-4927"],"issn-type":[{"type":"print","value":"0006-2928"},{"type":"electronic","value":"1573-4927"}],"subject":[],"published":{"date-parts":[[2024,5,7]]},"assertion":[{"value":"27 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The writers affirm that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The research protocols involving human subjects underwent a thorough review process. They received approval from the Iranian Registry of Clinical Trials (IR.SSU.MEDICINE.REC.1402.123) or the Yazd University of Medical Sciences Research Ethics Committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Patients provided written informed permission before study-related procedures and consented to publication of the results.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}